MENU
IBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ImmunityBio (IBRX) Ownership - Who owns ImmunityBio?
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.37B
P/E Ratio
N/A
Total Cash
149.81M
Projected Growth
N/A
Total Debt
504.17M
Revenue
14.75M
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
IBRX
Capitalization
2.37B
P/E Ratio
N/A
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash
150M
Total Cash/Share
0.17
Total Debt
504M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
14.7M
ROE
N/A
Book Value
-489.1M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
3.36
Current Revenue Per Employee
11105.88
Dividends Per Share - Security
N/A
EBITDA
-264.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-93.21
Shares Held By Institutions
333M
Shares Outstanding - Current
882M
Total Liabilities
871M
Total Volume MTD
N/A
Value
1
Gain YTD
4.688
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a producer of cancer treatment products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com